The report is the latest indictment of America’s broken healthcare system.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
Zacks.com on MSN5h
FTC Report Reveals PBM Practices Impacting Competition and Drug CostsThe FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Margin expansion at Express Scripts, Caremark and Optum Rx increased by $336 million between 2017 and 2021, officials say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback